Feed OASMY
OA

Vivesto AB OASMY OTC · Healthcare · Sweden

$0.00 +0.00% +$0.00

Market cap
63.8K kr
Enterprise value
-41.7K kr
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/FCF
-
EV/EBITDA
-
ROIC
-256.4%
Gross margin
-
Net margin
-
Dividend yield
676.00%
Payout ratio
-
Net debt/EBITDA
0.0x
Beta
1.75
Free float
50.4%

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Erik Kinnman

Employees

4

Headquarters

Solna

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

  • What speaks for it: It could repay all its net debt from 0.0 years of operating profit.
  • What to watch: It passes only 1 of the 9 points of the Piotroski financial health test.
  • What to watch: For every 100 SEK of bills due within a year it has 38 SEK of short-term assets.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy